| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |